Abstract BACKGROUND The prevalence of lower extremity artery disease (LEAD) is high (20%-25%) in the population older than 65 years, but patients are seldom identified until the disease is advanced. Circulating markers of disease activity might provide patients with a key opportunity for timely treatment. We tested the hypothesis that measuring blood-specific fragments generated during degradation […]
Assessment of extracellular matrix-related biomarkers in patients with lower extremity artery disease.
October 1, 2018
J Vasc Surg